tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BridgeBio price target raised to $86 from $80 at Truist
PremiumThe FlyBridgeBio price target raised to $86 from $80 at Truist
26d ago
BridgeBio initiated with an Overweight at Morgan Stanley
Premium
The Fly
BridgeBio initiated with an Overweight at Morgan Stanley
28d ago
BridgeBio Pharma: Emerging Rare Disease Leader With Robust Growth Outlook and Discounted Valuation Supporting Buy Rating
Premium
Ratings
BridgeBio Pharma: Emerging Rare Disease Leader With Robust Growth Outlook and Discounted Valuation Supporting Buy Rating
28d ago
BridgeBio initiated with an Outperform at Bernstein
PremiumThe FlyBridgeBio initiated with an Outperform at Bernstein
2M ago
BridgeBio Pharma: Buy Rating Backed by Promising Drug Pipeline and Strategic Market Positioning
Premium
Ratings
BridgeBio Pharma: Buy Rating Backed by Promising Drug Pipeline and Strategic Market Positioning
2M ago
BridgeBio presents BBO-10203 data at San Antonio Breast Cancer Symposium
Premium
The Fly
BridgeBio presents BBO-10203 data at San Antonio Breast Cancer Symposium
2M ago
BridgeBio Pharma’s Earnings Call Highlights Success and Challenges
PremiumCompany AnnouncementsBridgeBio Pharma’s Earnings Call Highlights Success and Challenges
3M ago
BridgeBio price target raised to $80 from $66 at Truist
Premium
The Fly
BridgeBio price target raised to $80 from $66 at Truist
3M ago
BridgeBio price target raised to $95 from $60 at TD Cowen
Premium
The Fly
BridgeBio price target raised to $95 from $60 at TD Cowen
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100